Brief: Onxeo Q1 revenue up 55 pct to 1.2 million euros
April 26 (Reuters) - Onxeo SA C4X.PA :
* Q1 revenue up 55 pct to EUR 1.2 million ($1.3 million)
* Cash position of EUR 21.7 million at March 31, 2017
Source text for Eikon: ID:nBw63cWLBa
Further company coverage: C4X.PA
($1 = 0.9200 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln